Riyadh – Mubasher: Miral Medical Clinics has officially announced the opening of nominations for its Board of Directors for the upcoming four-year term, according to a bourse filing.
The company is seeking to elect five members to lead the organization during the session scheduled to run from 26 October 2026 through 25 October 2030.
The nomination process is governed by the regulatory frameworks established by the Saudi Ministry of Commerce’s Companies Law and the Corporate Governance Regulations issued by the Capital Market Authority (CMA).
Furthermore, the process adheres to the specific policies, standards, and procedures for board membership approved by the company’s general assembly.
MIral Medical Clinics added that Shareholders interested in nominating themselves or others for the five available seats must submit their applications within the designated window during the period from 3 June 2026 until the close of business on 3 July 2026.
Miral Medical Clinics has outlined several eligibility requirements and criteria for prospective candidates. Notably, a nominee may not hold board memberships in more than five listed joint-stock companies simultaneously.
Candidates are required to submit a comprehensive application package to the Chairman of the Board. This package must include a completed and signed company nomination form, the CMA’s Curriculum Vitae Form 1, and the CMA’s Board Membership Nomination Form 3.
Additionally, applicants must provide a detailed resume highlighting their professional background, current primary occupation, academic qualifications, and relevant experience within the company’s field of operations.
Candidates are also required to disclose any current or previous board memberships in other joint-stock companies, including details on the committees they served on and the legal structure of those entities.
A critical component of the application involves the disclosure of potential conflicts of interest. Nominees must declare any direct or indirect interests in contracts or businesses conducted for the company's account, as well as any involvement in activities that may compete with Miral Medical Clinics or its various branches.
For candidates who have previously served on the company’s board, the application must include a statement from the company management regarding the most recent term. This statement should detail attendance records for board and committee meetings to demonstrate the level of engagement during the previous cycle.
All submitted documents and certificates must be provided in the Arabic language.
Following the close of the nomination period, Miral Medical Clinics will review the applications to ensure they meet all regulatory and internal standards. The final election of the board members will take place during a future General Assembly meeting, the date of which will be announced following the receipt of necessary approvals from relevant authorities.
The election will utilize the cumulative voting system, a standard practice designed to provide a fair representation of shareholder interests in the selection of the five-member board.
This transition to a new board term represents a standard regulatory cycle intended to ensure continued governance and strategic oversight for the company’s operations through 2030.
